Home » Topics » BioWorld Science

BioWorld Science
RSS

New SERD discovered by dynamics simulation shows promise for breast cancer therapy

July 30, 2021

MindMed begins phase I study of DMT

July 30, 2021

180 Life Sciences selects lead synthetic CBD analogue for inflammation and pain

July 30, 2021

Reyoung divulges new autophagy inhibitors

July 30, 2021

LegoChem Biosciences descibes new antibody-drug conjugates

July 30, 2021

New DNA-dependent protein kinase inhibitors identified at Chengdu Baiyu Pharmaceutical

July 30, 2021

Dizal (Jiangsu) Pharmaceutical discovers Bruton tyrosine kinase inhibitors

July 30, 2021

Proof-of-concept study of two targeted phage-based vaccination approaches against SARS-CoV-2

July 30, 2021

Blueprint Medicines and MD Anderson collaborate on advancing CDK2 inhibitor BLU-222

July 29, 2021

FDA clears INDs for targeted alpha therapy FPI-1966 and imaging agent FPI-1967

July 29, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...